查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
无晶体眼市场规模、份额和成长分析（按类型、最终用户、治疗方法和地区划分）—2026-2033年产业预测
市场调查报告书
商品编码
1916041

无晶体眼市场规模、份额和成长分析（按类型、最终用户、治疗方法和地区划分）—2026-2033年产业预测

Aphakia Market Size, Share, and Growth Analysis, By Type (Acquired Aphakia, Congenital Aphakia), By End User (Hospitals, Ophthalmic clinics), By Treatment, By Region - Industry Forecast 2026-2033
出版日期: | 出版商: SkyQuest | 英文 184 Pages | 商品交期: 3-5个工作天内

价格
简介目录

全球无晶体眼市场规模预计在 2024 年达到 20 亿美元，从 2025 年的 22.3 亿美元增长到 2033 年的 52.5 亿美元，在预测期（2026-2033 年）内复合年增长率为 11.3%。

白内障病例的增加、人口老化以及因意外事故和运动伤害导致的眼外伤发生率上升，正推动全球无晶体眼市场显着成长。这些因素会导致水晶体脱位，因此需要进行无晶体眼治疗。晶状体设计的创新和治疗效果的提升也促进了市场需求。大众对眼健康和早期疗育意识的提高也发挥了关键作用。政府措施和行动诊所的普及提高了医疗服务的可近性，推动了治疗的广泛应用。此外，人工智慧、机器学习、物联网和扩增实境等先进技术的融合，透过实现更精准的诊断、更完善的外科医生培训和更即时的病患监测，正在改变市场格局，最终改善手术效果和患者满意度。

全球无晶体眼市场驱动因素

全球无晶体眼市场受到白内障手术技术进步的显着影响。白内障手术透过摘除眼球的天然水晶体，导致对有效无晶体眼治疗方法的需求不断增长。随着越来越多的医疗专业人员将白内障手术作为高风险手术患者的首选治疗方案，该市场持续扩张。此外，各地医疗服务可近性的提高也导致无晶体眼病例增加，从而推动了市场成长。这一趋势表明，市场对创新解决方案的需求日益增长，以应对无晶体眼带来的挑战，这为医疗产业的现有企业和新兴企业都创造了成长机会。

限制全球无晶体眼市场的因素

全球无晶体眼市场面临诸多限制因素，主要原因在于治疗方案的高昂费用。无晶体眼治疗通常包括人工水晶体、特殊隐形眼镜或复杂的手术，这些治疗费用可能非常昂贵。沉重的经济负担使得许多患者无法获得治疗。此外，製造商难以在保持价格可负担性的同时，确保有效治疗所需的精准性和安全性。因此，这些经济因素构成了障碍，阻碍了无晶体眼患者的治疗方法的广泛应用和普及。

全球无晶体眼市场趋势

全球无晶体眼市场正经历强劲成长，这主要得益于患者和眼科医生对人工水晶体（IOL）需求的不断增长。人们对人工水晶体益处的认识不断提高，显着推动了人工水晶体的手术需求。此外，微创手术的趋势，例如提高患者舒适度和缩短恢復时间，也进一步推动了市场发展。水晶体技术的创新和白内障患者数量的成长，为人工水晶体的普及应用创造了有利环境，从而改变了治疗模式。这正在改变全球白内障和无水晶体眼的治疗方式。

目录

介绍

  • 调查目标
  • 调查范围
  • 定义

调查方法

  • 资讯收集
  • 二手资料和一手资料方法
  • 市场规模预测
  • 市场假设与限制

执行摘要

  • 全球市场展望
  • 供需趋势分析
  • 细分市场机会分析

市场动态与展望

  • 市场规模
  • 市场动态
    • 驱动因素和机会
    • 限制与挑战
  • 波特分析

关键市场考察

  • 关键成功因素
  • 竞争程度
  • 关键投资机会
  • 市场生态系统
  • 市场吸引力指数（2025）
  • PESTEL 分析
  • 总体经济指标
  • 价值链分析
  • 定价分析
  • 案例研究

全球无晶体眼市场规模（按类型及复合年增长率划分）（2026-2033 年）

  • 后天性无晶体
  • 先天性无晶体

全球无晶体眼市场规模（依最终用户划分）及复合年增长率（2026-2033 年）

  • 医院
  • 眼科诊所
  • 其他的

全球无晶体眼市场规模（按治疗方法和复合年增长率划分）（2026-2033 年）

  • 眼镜
  • 隐形眼镜
  • 人工水晶体植入术
  • 屈光矫正手术

全球无晶体眼市场规模及复合年增长率（2026-2033）

  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 德国
    • 西班牙
    • 法国
    • 英国
    • 义大利
    • 其他欧洲地区
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 亚太其他地区
  • 拉丁美洲
    • 巴西
    • 其他拉丁美洲地区
  • 中东和非洲
    • 海湾合作委员会国家
    • 南非
    • 其他中东和非洲地区

竞争资讯

  • 前五大公司对比
  • 主要企业的市场定位（2025 年）
  • 主要市场参与者所采取的策略
  • 近期市场趋势
  • 公司市占率分析（2025 年）
  • 主要企业公司简介
    • 公司详情
    • 产品系列分析
    • 依业务板块进行公司股票分析
    • 2023-2025年营收年比比较

主要企业简介

  • Johnson & Johnson Vision（Johnson & Johnson Services Inc.）
  • Alcon Laboratories Inc.
  • Carl Zeiss AG（ZEISS International）
  • Bausch+Lomb Incorporated
  • Rayner Intraocular Lenses Limited
  • Ophtec BV
  • CooperVision Inc.
  • Hoya Corporation
  • Menicon Co. Ltd.
  • Bohus BioTech AB
  • Lifecore Biomedical, LLC
  • Mediphacos
  • Santen Pharmaceutical Co. Ltd.
  • UltraVision CLPL

结论与建议

简介目录
Product Code: SQMIG35A3108

Global Aphakia Market size was valued at USD 2 Billion in 2024 and is poised to grow from USD 2.23 Billion in 2025 to USD 5.25 Billion by 2033, growing at a CAGR of 11.3% during the forecast period (2026-2033).

The global aphakia market is witnessing significant growth driven by an increase in cataract cases, a rising aging population, and a heightened incidence of eye trauma due to accidents and sports injuries. These factors lead to lens dislocation and necessitate treatment for aphakia. Enhanced lens design innovations contribute to improving treatment outcomes, further boosting demand. Growing public awareness regarding eye health and early intervention also plays a crucial role. Increased healthcare access through government initiatives and mobile clinics facilitates wider treatment adoption. Additionally, the integration of advanced technologies such as AI, machine learning, IoT, and augmented reality is transforming the market by enabling better diagnosis, training for surgeons, and real-time patient monitoring, ultimately improving surgical outcomes and patient satisfaction.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Aphakia market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Aphakia Market Segments Analysis

Global Aphakia Market is segmented by Type, End User, Treatment and region. Based on Type, the market is segmented into Acquired Aphakia and Congenital Aphakia. Based on End User, the market is segmented into Hospitals, Ophthalmic clinics and Others. Based on Treatment, the market is segmented into Spectacles, Contact Lenses, Intraocular Lens Implantation and Refractive Surgery. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Aphakia Market

The global Aphakia market is significantly influenced by developments in cataract surgery, where the removal of the eye's natural lens creates a growing demand for effective aphakia treatment options. As more healthcare professionals prioritize cataract removal in patients with heightened surgical risks, the market continues to expand. Additionally, improved access to healthcare in various regions is resulting in a higher incidence of aphakia cases, thereby driving market growth. This trend highlights the increasing need for innovative solutions to address the challenges associated with aphakia, fostering opportunities for both established companies and emerging players within the healthcare industry.

Restraints in the Global Aphakia Market

The Global Aphakia market faces significant restraints primarily due to the high costs associated with treatment options. Addressing aphakia typically involves the use of intraocular lenses, specialized contact lenses, or intricate surgical procedures, all of which can be prohibitively expensive. This financial burden limits access to treatment for many patients. Furthermore, manufacturers struggle to strike a balance between maintaining affordability and delivering the precision and safety essential for effective aphakia management. As a result, these economic factors create barriers that hinder the widespread adoption and availability of necessary treatments for individuals affected by this condition.

Market Trends of the Global Aphakia Market

The Global Aphakia market is experiencing robust growth, driven by a heightened demand for intraocular lenses (IOLs) among both patients and ophthalmologists. This rising awareness about the advantages of IOLs is significantly propelling interest in intraocular lens-based surgeries. Additionally, the trend towards minimally invasive procedures, which offer enhanced patient comfort and expedited recovery times, is further fueling the market. Innovations in lens technology and the increasing prevalence of cataracts are contributing to a favorable environment for IOL adoption, leading to a shift in treatment paradigms and transforming the landscape of cataract and aphakia management worldwide.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2025
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis
  • Case Studies

Global Aphakia Market Size by Type & CAGR (2026-2033)

  • Market Overview
  • Acquired Aphakia
  • Congenital Aphakia

Global Aphakia Market Size by End User & CAGR (2026-2033)

  • Market Overview
  • Hospitals
  • Ophthalmic clinics
  • Others

Global Aphakia Market Size by Treatment & CAGR (2026-2033)

  • Market Overview
  • Spectacles
  • Contact Lenses
  • Intraocular Lens Implantation
  • Refractive Surgery

Global Aphakia Market Size & CAGR (2026-2033)

  • North America (Type, End User, Treatment)
    • US
    • Canada
  • Europe (Type, End User, Treatment)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Type, End User, Treatment)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Type, End User, Treatment)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Type, End User, Treatment)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2025
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2025
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

  • Johnson & Johnson Vision (Johnson & Johnson Services Inc.)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Alcon Laboratories Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Carl Zeiss AG (ZEISS International)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bausch + Lomb Incorporated
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Rayner Intraocular Lenses Limited
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Ophtec BV
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • CooperVision Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Hoya Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Menicon Co. Ltd.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bohus BioTech AB
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Lifecore Biomedical, LLC
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Mediphacos
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Santen Pharmaceutical Co. Ltd.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • UltraVision CLPL
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations